Singapore Institute Of Advanced Medicine Holdings Ltd

SGX:9G2 (Singapore)  
S$ 0.08 (0%) Nov 29
N/A
P/B:
1.02
Market Cap:
S$ 83.85M ($ 62.60M)
Enterprise V:
S$ 126.78M ($ 94.65M)
Volume:
-
Avg Vol (2M):
89.20K
Trade In:
Avg Vol (2M):
89.20K

Business Description

Singapore Institute Of Advanced Medicine Holdings Ltd

ISIN : SGXE79544776
Compare
Compare
Traded in other countries / regions
9G2.Singapore
IPO Date
2024-02-16
Description
Singapore Institute Of Advanced Medicine Holdings Ltd is a healthcare service provider using advanced technology for early and accurate diagnosis, It is engaged in the following business segments Medical Diagnostics and Treatments, Radiation Therapy and Medical Oncology Services. Medical diagnostics and treatments which cover (i) cancer-related diagnostics and theranostics treatments; (ii) general diagnostics and health screening; and (iii) aesthetic services Medical diagnostics and treatments which cover (i) cancer-related diagnostics and theranostics treatments; (ii) general diagnostics and health screening; and (iii) aesthetic services. Maximum revenue is generated from generated from Medical Diagnostics and Treatments.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 0.07
Equity-to-Asset 0.59
Debt-to-Equity 0.56
Debt-to-EBITDA N/A
N/A
N/A
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -0.89
Distress
Grey
Safe
Beneish M-Score -3.52
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 98.06
9-Day RSI 87.53
14-Day RSI 74.35
6-1 Month Momentum % -25

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.37
Quick Ratio 0.36
Cash Ratio 0.25

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -1.3

Profitability Rank

Name Current Vs Industry Vs History
FCF Margin % -80.88

Financials

SGX:9G2's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Singapore Institute Of Advanced Medicine Holdings Ltd Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil S$) 16.646
EPS (TTM) (S$) 0
Beta 0
Volatility % 0
14-Day RSI 74.35
14-Day ATR (S$) 0.00136
20-Day SMA (S$) 0.0687
12-1 Month Momentum % 0
52-Week Range (S$) 0.062 - 0.195
Shares Outstanding (Mil) 1,048.1

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Singapore Institute Of Advanced Medicine Holdings Ltd Filings

Filing Date Document Date Form
No Filing Data

Singapore Institute Of Advanced Medicine Holdings Ltd Stock Events

Financials Calendars
Event Date Price(S$)
No Event Data

Singapore Institute Of Advanced Medicine Holdings Ltd Frequently Asked Questions

What is Singapore Institute Of Advanced Medicine Holdings Ltd(SGX:9G2)'s stock price today?
The current price of SGX:9G2 is S$0.08. The 52 week high of SGX:9G2 is S$0.20 and 52 week low is S$0.06.
When is next earnings date of Singapore Institute Of Advanced Medicine Holdings Ltd(SGX:9G2)?
The next earnings date of Singapore Institute Of Advanced Medicine Holdings Ltd(SGX:9G2) is .
Does Singapore Institute Of Advanced Medicine Holdings Ltd(SGX:9G2) pay dividends? If so, how much?
Singapore Institute Of Advanced Medicine Holdings Ltd(SGX:9G2) does not pay dividend.

Press Release

Subject Date
No Press Release